Of the 421 randomized patients , 411 ( 98 % ) were assessable for efficacy ; 69.6 % ( 142/204 ) and 57.0 % ( 118/207 ) of patients reported CR during the OP in the aprepitant and standard therapy groups , respectively ( P = 0.007 ) .